Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Phase 1/2 Unknown 24 enrolled Bundang CHA Hospital Korea Evaluation Institute of Industrial Technology · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial is a clinical trial for the evaluation of the safety and efficacy of umbilical cord blood (UCB) therapy, UCB and erythropoietin (EPO) combination therapy in adult stroke patients.

Timeline

Start: 2019-05-02
Primary completion: 2020-11-02
Completion: 2021-11-02

Publications

Kim JM, Shin S, Lee D, Choi JI, Kwon HG, Hwang SSS, Cho SM, Kim YH, Lee J, Moon HI, Suh MR, Kim M. Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke. Stem Cell Res Ther. 2025 Dec 27;17(1):56. doi: 10.1186/s13287-025-04856-8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Influenza Virus Vaccine	Vaccine	—	Intravenous
Comparator	epoetin alfa	Protein / enzyme biologic	500 iu/kg	Intravenous

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Summary

Timeline

Publications

Drugs

Indications